Ignite Creation Date:
2024-05-06 @ 3:41 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02341326
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-21
First Post:
2014-07-16
Brief Title:
Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Early changes associated with the development of smoking-induced diseases eg COPD and lung cancer the two commonest causes of death in US are often characterized by abnormal airway epithelial differentiation Airway basal cells BC are stemprogenitor cells necessary for generation of differentiated airway epithelium Based on our preliminary observations on SAE BC cells and FGFR2 signaling we hypothesized that suppression of FGFR2 signaling in the SAE BC stemprogenitor cells by cigarette smoking renders these cells less potent in generating and maintaining normally differentiated SAE shifting these cells towards a COPD associated phenotype To test this SAE basal cells will be isolated from cultured cells obtained through bronchoscopic brushings and analyzed through in vitro assays for their stemprogenitor capacities
Detailed Description:
Changes within the small airways of the lungs represent the key element in the mechanism of COPD as they precede the development of emphysema and contribute to the progressive decline in expiratory airflow One of the key features of COPD is the remodeling of the small airway epithelium SAE and COPD SAE phenotypes are often induced by smoking and broad gene expression changes in the SAE Many of the specific mechanisms for maintenance and regeneration of small airways and differentiated SAE in adult human lungs are largely unknown but smoking associated defects in the maintenance of the SAE may be an early event of COPD Preliminary data from murine studies have indicated that fibroblast growth factor receptor 2 FGFR2 signaling is critical for lung architecture and development and preliminary evidence has shown the FGFR2 pathway is down regulated within the small airway epithelium SAE of smokers and smokers with COPD We hypothesize that the suppression of FGFR2 signaling in SAE BC stem cells by cigarette smoking causes these cells to become less potent shifting the expression of normally differentiated SAE towards the COPD-associated small airway phenotype and therefore affecting the generation and maintenance of these cells Using technologies established in our laboratories pure populations of BC will be isolated from the SAE of healthy nonsmokers healthy smokers and COPD smokers The stemprogenitor cell capacities of the SAE BC of each group will then be analyzed through the use of 3D modeling The basic mechanisms of COPD will be tested by focusing on the phenotypes present in the lungs of COPD patients and comparison to their nonsmoker and healthy smoker counterparts The 3 aims will be assessed in parallel with all aims sharing in the biologic samples
Aim 1 n60 To determine whether BC from the SAE of COPD smokers have reduced capacity to generate normally differentiated SAE eg initiate airway branching and repair in response to injury in vitro but generate airway epithelium with the phenotype similar to that present in SAE of COPD smokers in vivo
Aim 2 n20 To test the hypothesis that FGFR2 signaling is necessary for normal SAE BC stem cell function and suppression of FGFR2 caused by inhibitors and smoking associated factors EGF and TGF- beta leads an altered stem cell functional phenotype similar to SAE BC from COPD smokers with reduced capacity as characterized by Aim 1
Aim 3 n40 To assess the hypothesis that increasing FGFR2 signaling and suppressing smoking induced EGF receptors and TGF-beta pathways will restore the FGFR2 expression and normalize the capacity of SAE BC stem cells to generate and maintain normally differentiated SAE
Aim 1 n60 To determine whether BC from the SAE of COPD smokers have reduced capacity to generate normally differentiated SAE eg initiate airway branching and repair in response to injury in vitro but generate airway epithelium with the phenotype similar to that present in SAE of COPD smokers in vivo
Aim 2 n20 To test the hypothesis that FGFR2 signaling is necessary for normal SAE BC stem cell function and suppression of FGFR2 caused by inhibitors and smoking associated factors EGF and TGF- beta leads an altered stem cell functional phenotype similar to SAE BC from COPD smokers with reduced capacity as characterized by Aim 1
Aim 3 n40 To assess the hypothesis that increasing FGFR2 signaling and suppressing smoking induced EGF receptors and TGF-beta pathways will restore the FGFR2 expression and normalize the capacity of SAE BC stem cells to generate and maintain normally differentiated SAE
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL123544 | NIH | None | httpsreporternihgovquickSearchR01HL123544 |